Dr. Jasielec is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. MARYLAND AVE.
Chicago, IL 60637Phone+1 773-702-8955Fax+1 773-702-3163- Is this information wrong?
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Vermont Medical CenterResidency, Internal Medicine, 2008 - 2011
Jagiellonian University Medical CollegeClass of 2008
Certifications & Licensure
IL State Medical License 2011 - 2023
VT State Medical License 2008 - 2011
Publications & Presentations
PubMed
- 2 citationsPhase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma.Benjamin A Derman, Jeffrey Zonder, Donna Reece, Craig Cole, Jesus Berdeja, Andrew T Stefka, Ajay Major, Andrew Kin, Kent Griffith, Jagoda Jasielec, Andrzej J Jakubowiak> ;Blood Advances. 2023 Oct 10
- 4 citationsA phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.Benjamin A Derman, Ajai Chari, Jeffrey Zonder, Ajay Major, Andrew T Stefka, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej Jakubowiak> ;European Journal of Haematology. 2023 May 1
- 1 citationsEfficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies.Ola Landgren, Dickran Kazandjian, Murielle Roussel, Jagoda Jasielec, Dominik Dytfeld, Aparna Anderson, Tara A Kervin, Karim Iskander, Ian McFadden, Andrzej J Jakubowiak> ;Leukemia & Lymphoma. 2022 Oct 1
- Join now to see all
Abstracts/Posters
- Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) TherapyJagoda K. Jasielec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell TherapyJagoda K. Jasielec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
